We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Results for
"[search-keyword]"
Sponsor content
79 result(s) found, displaying 1 to 10
-
Sep-2024Prescription medicine evaluationActive ingredient: ropinirole hydrochloride.
-
Jul-2024Prescription medicine evaluationActive ingredient: Diclofenac sodium.
-
-
Jul-2024Prescription medicine evaluationActive ingredient: oxybutynin hydrochloride.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUGAMMADEX MSN sugammadex (as sodium) 200 mg/2 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUGAMMADEX MSN sugammadex (as sodium) 500 mg/5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TICALOR ticagrelor 90 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUNITINIB MSN sunitinib (as malate) 12.5 mg hard capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUNITINIB MSN sunitinib (as malate) 37.5 mg hard capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUNITINIB MSN sunitinib (as malate) 37.5 mg hard capsule blister pack.